Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,226,774 papers from all fields of science
Search
Sign In
Create Free Account
clopidogrel
Known as:
Clopidogrelum
, clopidogrel [Chemical/Ingredient]
, methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate
a kind of anti-clotting drug
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Blood Coagulation Disorders
Cerebral Infarction
Coronary Thrombosis
Drug Allergy
Expand
Narrower (6)
Clopidogrel bisulfate
Iscover
Plavix
SR 25989
Expand
Broader (4)
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Thiophene
Ticlopidine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Issue Information ‐ Forthcoming Article
2017
Corpus ID: 29475676
No abstract is available for this article.
2012
2012
HIGH TOTAL LEUKOCYTE COUNT AND HEART FAILURE AFTER MYOCARDIAL INFARCTION
A. Jan
,
S. Habib
,
Khalid Naseeb
,
Mohammad Amir Khatri
,
K. S. Zaman
2012
Corpus ID: 70688758
Background: Acute myocardial infarction ST-elevation (STEMI) is frequently associated with leukocytosis and relative increased in…
Expand
2012
2012
Prevalence of inadequate platelet inhibition by clopidogrel in patients receiving hemodialysis.
D. Alexopoulos
,
I. Xanthopoulou
,
+5 authors
C. Fourtounas
American Journal of Kidney Diseases
2012
Corpus ID: 206201689
co.uk/lifestyle/technology-gadgets/how-google-can-tell-the-bankof-england-what-to-do-next-16011174.html. Accessed June 1, 2011. 9…
Expand
2011
2011
The IL-28B Genotype Predicts Which Slow-Responding Hepatitis C-Infected Patients Will Benefit from Treatment Extension
Brian L. Pearlman
,
C. Ehleben
American Journal of Gastroenterology
2011
Corpus ID: 27220545
The IL-28B Genotype Predicts Which Slow-Responding Hepatitis C-Infected Patients Will Benefit from Treatment Extension
2010
2010
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition
F. Szlam
,
Kenichi A. Tanaka
,
Brady Rumph
,
D. Bolliger
,
J. Levy
Thrombosis and Haemostasis
2010
Corpus ID: 40076712
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition -
2009
2009
SPECTROPHOTOMETRIC ESTIMATION OF CLOPIDOGREL BISULPHATE IN PHARMACEUTICAL DOSAGE FORMS
Yogita Shete
,
N. S. Mahajan
,
Y. Pore
,
R. Jadhav
,
B. Kuchekar
2009
Corpus ID: 98172205
A simple, sensitive, rapid, accurate and precise spectrophotometric method has been developed for estimation of clopidogrel…
Expand
Review
2008
Review
2008
Pharmacological approaches to preventing vascular access failure
K. Polkinghorne
Nephrology
2008
Corpus ID: 1348381
Date written: December 2006
2007
2007
Antiplatelet therapy after coronary occlusion
A. Mccann
2007
Corpus ID: 77973772
Platelets are pivotal in the pathogenesis of acute coronary syndrome and in the complications following the implantation of…
Expand
2005
2005
Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment
D. Mukherjee
,
E. Topol
,
+4 authors
S. Steinhubl
Heart
2005
Corpus ID: 46037549
Objective: To assess the effectiveness of long term treatment with clopidogrel of patients with extracardiac vascular disease…
Expand
2003
2003
Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested.
V. Serebruany
,
S. Steinhubl
,
C. Hennekens
Circulation
2003
Corpus ID: 1078320
With respect to antiplatelet therapy, randomized trials and their meta-analyses 1 indicate benefits of clopidogrel either as an…
Expand